Trump Administration To Back Marijuana Legalization

New Post Public Reply Private Reply Replies (0) Message Board
Maker13
189
Trump Administration To Back Marijuana Legalization



Trump Supports Legal Cannabis – Recreational and Medical



Below is the excerpt from the USMJ and PURA shareholder update analyzing Trump Administration the pro-legal marijuana stand:


President Trump is a populist president and “populist” is not necessarily a dirty word. Meriam-Webster defines populist as “a member of a political party claiming to represent the common people.” Now “populist” might be a dirty word if the actions of a politician only “claim” to represent the common people while the true intent is something else. Populist politics is sometimes compared to parenting. Parents shouldn’t always give children what they want. Except voters aren’t children. Please keep in mind, nothing here is intended to support or attack the Trump Presidency. Our interest is very specifically in the eventual federal legalization of cannabis, and in the meantime, a continued federal laissez fair policy toward states’ legalization of cannabis. Our intent here is to cut through barrage of opinionated, riot inspiring news to take a sober look at the reality of the cannabis situation when it comes to what the Federal Government may or may not do in regard to the enforcement of federal cannabis laws. From our vantage point, we believe the media reaction to Press Secretary Sean Spicer’s comments and Jeff Sessions stick in the mud personal opinion about cannabis is much ado about nothing.

It’s difficult to argue that President Trump is at least acting as a “populist” politician. We’ll leave it to you to judge his true populist intent. We believe giving voters what they want is a good thing and we hope that’s what President Trump is really up to. We won’t argue against characterizing President Trump as offensive. President Trump seems to have a gift when it comes to offensiveness. Many of us have a crotchety old relative, probably about President Trump’s age, that manages to insult everyone at the Thanksgiving table, but he’s family and everyone still loves him.

So Press Secretary Spicer makes some disturbing comments about the Federal Government enforcing federal marijuana laws in spite of local state marijuana legalization. However, a few days later, Attorney General Jeff Sessions issued a statement to counter balance Press Secretary Spicer’s earlier comments. Attorney General Sessions talked about “responsible laws,” and acknowledging states’ rights to “pass the laws they choose.” An optimistic interpretation of the disturbing statements followed by a balancing counter-statement might be that the Trump Administration is attempting to find a “populist” balance. While giving voters what they want might be a lofty idea, not all voters want the same thing. In fact, voters can often be at odds as to what they want. Every issue in America can’t logistically be taken to a popular vote. It might be sheer genius to test the waters on issues by suggesting an extreme policy; afterwards assessing the reaction to the extreme policy suggestion, and ultimately backing off from the extreme suggestion to simply implement a practical policy that the majority of voters can all tolerate. Press Secretary Spicer just might be the White House sonar pinging for mines so the White House can steer clear and maneuver through populist waters.

Remember the transitive property from high school math? If A=B. and B=C, then A=C. Ok, so it appears that an anti-marijuana sentiment exists amongst those voters that put Trump in the White House. President Trump, crotchety old relative charisma aside, might deserve some credit for trying to acknowledge the sentiments of those that elected him. However, clearly the majority of Americans are pro marijuana legalization. If President Trump is a true populist trying to give voters what they want (not just the voters that voted for him), and if the majority voters want legal marijuana, then A=C and President Trump’s Administration will not only support states marijuana laws, but eventual federal marijuana legalization overall.

Some may think President Trump is not a genuine populist and that he is only laying claim to a populist agenda in order to advance some nefarious counter agenda. If that’s the case, let’s have faith that the American people will do what they do and rise to the occasion in the face of such treachery. Either way, if he’s a really a populist, legal cannabis is safe. If he’s poser with a nefarious agenda, the American people will do what they do and cannabis is still safe.

Wall Street Corner Report is the premier discovery site for promising, yet undiscovered small and micro-cap stocks featuring opportunities in an ethical, professional, and responsible manner. We're not fiendishly 'short' sighted nor are we here to dream the impossibly 'long' dream. We take a practical view on the big ideas of well-intentioned management and look to profit on each reasonably achievable step the well intentioned mangers take toward their big ideas.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Black Friday Doubt Grows: Just 54% Trust Real Deals

Updated Category News Views 127

Do Shoppers Believe in Black Friday Anymore? You'd think by now, retailers would have cracked the code on building trust with their customers. But guess what? A fresh survey from Boston Consulting Group reveals only 54% of consumers buy the whole Black Friday discount story. That's barely more than flipping a coin. Promotion Fatigue: The Trust Buster Funny thing,...

Continue Reading
Young Storytellers Honored: Bridging Cultures Through Journalism

Updated Category News Views 6

Leaders of Tomorrow: Campus News Awards 2026 It's no small feat to look at a room full of young journalists and see the future of how stories will be told. But that's exactly what happened at the Campus News Awards 2026 in Shenzhen. Here, kids from Hong Kong, Macao, Taiwan, and Southeast Asia stood proudly with their certificates, ready to tackle the changing landscape of...

Continue Reading
TSX Surges Amid Earnings Wave and Market Momentum

Updated Category News Views 46

TSX Soars, But What's Driving the Surge? Gotta say, when the TSX leaps over 2% in a single day, it sets the stage for two things: excitement and scrutiny. On a balmy Wednesday, Canada's stock market stood tall at 36,317.67, up 785.39 points. Wall Street joined the dance too, with the Dow kicking up by 1,543.75 points. Good vibes all around — but hang on a minute. You...

Continue Reading
Marini SkinSolutions Wins with Night Zyme Complex

Updated Category News Views 13

Shaking Up the Skincare Scene You don't often see a skincare product snag three prestigious awards in one year, but that's exactly what's unfolding for Marini SkinSolutions. This time, their Night Zyme® Overnight Glass Skin Resurfacing Complex grabbed the 2026 Shop TODAY Ageless Beauty Award. It’s turning heads and not just in beauty aisles but among investors eyeing a...

Continue Reading
Defense Contractors Eye Larger Backlogs Amid Funding Uncertainty

Updated Category News Views 144

Playing Chicken with Federal Deadlines We've got ourselves a situation where defense contractors are juggling bigger backlogs while the clock ticks down to a looming federal funding deadline on December 11. If this sounds like a high-stakes game of chicken, it's because it is. No one knows if Congress will stitch things up before the stopgap funding dries up. Hell, maybe...

Continue Reading
MAURE's Three-Year Mark: Crafting Home Elegance

Updated Category News Views 39

Brooklyn's Gem: MAURE Turns Three Over in Brooklyn, there's a brand bubbling with style called MAURE. Now, we're talking three years strong, surviving the wild bout of the retail scene with a firm two feet planted in home and gifting. The Vision Turned Reality When Maureen Cavalieri, a hospitality veteran since 2009, first tossed this spark into the wind in 2023, it...

Continue Reading
Trimble's Q3 2026: Guidance Update and Record ARR

Updated Category News Views 89

Trimble Smashes Through Q3 Expectations Trimble Inc. (NASDAQ:TRMB) tossed a bit of a curveball by posting Q3 2026 results that sailed past analyst forecasts. We’re talking revenue swelling to $966.8 million, a decent 7% bump from the previous year. Now, for a company riding its 'Connect & Scale' strategy, this serves as a validation of its aggressive scaling ambitions....

Continue Reading
Duolingo Faces Class Action: Investors React Strongly

Updated Category News Views 63

Duolingo's Rough Road: A Lawsuit in Motion Alright, fasten your seatbelts, because we've got a real rollercoaster here with Duolingo (NASDAQ: DUOL). You know, the language-learning app that's been pushing ads like it's going out of style? Well, investors are seeing red—not the kind you want, either. This class action lawsuit looming over them is like an unwelcome...

Continue Reading
Natixis' $100M Student Challenge Mixes Real Stakes

Updated Category News Views 127

Opportunity Knocks for Budding Portfolio Managers Picture this: You're a student, neck-deep in textbooks and theories, and then bam! You're handed the keys to manage a $100 million portfolio. That's the real-deal opportunity Natixis Investment Managers is dangling with its seventh Students Challenge. Diving Into the Nuts and Bolts Listen up, kids. Applications are open...

Continue Reading
NACCO Navigates Strong 2026 Q3, Faces Solar Cost Hurdles

Updated Category News Views 34

Rolling With NACCO's Financial Punches Well, folks, when it rains, it pours—numbers that is. NACCO Industries just laid out their Q3 results for all to gawk at, and it's a mixed bag of triumphs and tussles. You got a gross profit of $11.8 million, a sweet 18% jump on the same quarter last year. Now, you're talking about revenue muscle, and there it is. Income before...

Continue Reading

Top 5 Most Recently Viewed Articles

Vantiva Launches Cutting-Edge DOCSIS 4.0 FDD Cable Modem

Updated Category News Views 825

Vantiva Unveils Game-Changing DOCSIS 4.0 FDD Modem Vantiva, a prominent name in technology solutions, has introduced the Marlin Xe (CXA500Z), the first commercially available DOCSIS 4.0 Frequency Division Duplex (FDD) Cable Modem. This groundbreaking product is designed to allow service providers to deliver outstanding data speeds that rival the performance of...

Continue Reading
AST Welcomes Jacob Stephen as New Chief Operating Officer

Updated Category News Views 194

AST Welcomes Jacob Stephen as Chief Operating Officer Stephen to lead company-wide execution, strengthening AST's Executive Leadership Team AST is thrilled to announce that Jacob Stephen will be joining the AST Team as Chief Operating Officer at the drug product equipment manufacturing company headquartered in Tacoma. Jacob joins from IPS, where he excelled as Head of...

Continue Reading
Celebrating Bravery: Broward Sheriff's Heroes Recognized

Updated Category News Views 244

Ceremony Highlights Bravery and Dedication The Broward Sheriff's Advisory Council recently hosted a remarkable event dedicated to honoring the exceptional bravery and commitment of first responders in the community. This annual Tribute to Bravery ceremony took place at a beautiful venue by the beach, bringing together heroes and supporters alike. Acknowledging Local...

Continue Reading
Insight into Recent Riksbank Government Bond Auctions

Updated Category News Views 194

Overview of Riksbank Auctions for Government Bonds The Riksbank, Sweden's central bank, frequently holds auctions for government bonds as a way to manage monetary policy and influence the economy. These auctions are significant for investors, economists, and financial analysts who closely monitor the outcomes, as they provide insights into market sentiment and interest...

Continue Reading
Innovative Approaches in Neuroblastoma Treatment by Y-mAbs

Updated Category News Views 235

Y-mAbs Shares New Developments in Neuroblastoma Treatment Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB), a leading biopharmaceutical company dedicated to advancing cancer therapies, has announced exciting new research focused on treating neuroblastoma through innovative technologies. Recent clinical and preclinical findings related to naxitamab and the GD2-SADA platform were...

Continue Reading